Strategies to disrupt NKG2A:HLA-E interactions for improved anti-cancer immunity

Oncotarget. 2024 Jul 17:15:501-503. doi: 10.18632/oncotarget.28610.

Jack G Fisher, Lara V Graham, Matthew D Blunt

PMID: 39018202 DOI: 10.18632/oncotarget.28610

Keywords

HLA-E; NKG2A; Natural killer (NK) cells; immune checkpoint blockade; immunotherapy.

Products

Cat. No.

Product Name

Description

Target

Research Area
HY-P991058

Zimistobart

NKG2A Antibody

Checkpoint Kinase (Chk)

Cancer

MedChemExpress Magic Cece

MedChemExpress: Contact Us; About Us; Headquarters; Distributors; Statement on False Report; Careers

Customer Support: Technical Support; Service; Ordering Information; Easy Return; Shipping Rates & Policies; Intellectual Property Promise

Resources: Free Sample; Resources; Molarity Calculator; Dilution Calculator; Terms & Conditions; Reconstitution Calculator; Specific Activity Calculator; DNA/RNA sequence conversion tools

Subscribe to our E-newsletter

Name
Email *

	Sorry, but the email address you supplied was invalid.

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.

Copyright © 2013-2025 MedChemExpress. All Rights Reserved.: Site Map Privacy Policy

Join with us